our products
Contact phone

Tadalis® Sx

Erectile Dysfunction Tadalis Sx (Generic) Generic drugs, marketed without brand names, contain the exact same active ingredients used in their brand-name counterparts, but cost significantly less. The drugs are required to meet US Food and Drug Administration (FDA) standards for safety, purity and effectiveness.
Tadalis Sx

Tadalis® Sx is a medication that is prescribed to patients who are experiencing issues with their sexual function, such as impotence or erectile dysfunction. Ajanta is the company that produces it. The primary active component, which is also found in Cialis®, is called tadalafil.

BEST DEAL!

Save 20% with

Coupon "PKVCbYFj9G"

Product Options

Qty Price Per pill Savings
12 tablet $ 49.95

Best Deal

$ 4.16
Sold out
20 tablet $ 57.95

Best Deal

$ 2.90 $ 25.30
Sold out
32 tablet $ 65.95

Best Deal

$ 2.06 $ 67.25
Sold out
60 tablet $ 113.95

Best Deal

$ 1.90 $ 135.80
Sold out
92 tablet $ 152.95

Best Deal

$ 1.66 $ 230.00
Sold out
120 tablet $ 191.95

Best Deal

$ 1.60 $ 307.55
Sold out
180 tablet $ 269.95

Best Deal

$ 1.50 $ 479.30
Sold out

Generic Tadalis-SX: A Comprehensive Overview

Introduction

Generic Tadalis-SX is a medication widely recognized for its efficacy in treating erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). It is the generic version of the brand-name drug Tadalafil, which is marketed under various names, including Cialis. Tadalafil belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors, which work by increasing blood flow to specific areas of the body, particularly the penis, to facilitate an erection. Generic Tadalis-SX has gained popularity due to its affordability and effectiveness, making it a preferred choice for many individuals seeking treatment for ED and PAH.

Mechanism of Action

The primary mechanism of action of Generic Tadalis-SX involves the inhibition of the PDE5 enzyme. PDE5 is responsible for the breakdown of cyclic guanosine monophosphate (cGMP), a molecule that promotes smooth muscle relaxation and increased blood flow in the penis. By inhibiting PDE5, Generic Tadalis-SX allows cGMP levels to rise, leading to the relaxation of smooth muscles in the penile arteries and enhanced blood flow. This process is essential for achieving and maintaining an erection during sexual stimulation.

In the context of pulmonary arterial hypertension, Generic Tadalis-SX helps by relaxing the blood vessels in the lungs, thereby reducing the pressure in the pulmonary arteries. This alleviates the symptoms of PAH, such as shortness of breath, fatigue, and chest pain, and improves the patient's ability to engage in physical activities.

Indications and Uses

  1. Erectile Dysfunction (ED):
    Generic Tadalis-SX is primarily prescribed for the treatment of erectile dysfunction, a condition characterized by the inability to achieve or sustain an erection sufficient for satisfactory sexual performance. It is effective in men of various age groups and can be used on an as-needed basis or as a daily low-dose treatment, depending on the severity of the condition and the patient's preference.

  2. Pulmonary Arterial Hypertension (PAH):
    In addition to its use in ED, Generic Tadalis-SX is also indicated for the management of pulmonary arterial hypertension. It helps improve exercise capacity and delay clinical worsening in patients with PAH, making it a valuable therapeutic option for those suffering from this debilitating condition.

Dosage and Administration

The dosage of Generic Tadalis-SX varies depending on the condition being treated and the patient's response to the medication. For erectile dysfunction, the typical recommended dose is 10 mg, taken prior to anticipated sexual activity. The dose can be adjusted to 20 mg or reduced to 5 mg based on efficacy and tolerability. For daily use, a lower dose of 2.5 mg or 5 mg is often prescribed.

For pulmonary arterial hypertension, the usual dose is 40 mg once daily, which may be adjusted based on the patient's clinical response and tolerability. It is important to follow the prescribing physician's instructions and not to exceed the recommended dosage to avoid potential side effects.

Pharmacokinetics

Generic Tadalis-SX is well-absorbed after oral administration, with peak plasma concentrations reached within 2 hours. It has a long half-life of approximately 17.5 hours, which allows for a prolonged duration of action compared to other PDE5 inhibitors like sildenafil (Viagra). This extended half-life is one of the key advantages of Generic Tadalis-SX, as it provides a wider window of opportunity for sexual activity and reduces the need for precise timing of medication intake.

The drug is primarily metabolized in the liver by the cytochrome P450 3A4 (CYP3A4) enzyme and is excreted mainly in the feces (approximately 61% of the dose) and urine (about 36% of the dose). The pharmacokinetics of Generic Tadalis-SX may be influenced by factors such as age, renal or hepatic impairment, and concomitant use of other medications.

Side Effects and Adverse Reactions

Like all medications, Generic Tadalis-SX may cause side effects, although not everyone experiences them. Common side effects include:

  • Headache

  • Flushing

  • Indigestion

  • Nasal congestion

  • Back pain

  • Muscle aches

These side effects are generally mild to moderate in severity and tend to resolve on their own as the body adjusts to the medication. However, if any of these side effects persist or worsen, it is important to consult a healthcare provider.

In rare cases, Generic Tadalis-SX may cause more serious side effects, such as:

  • Sudden vision loss (non-arteritic anterior ischemic optic neuropathy, NAION)

  • Sudden hearing loss

  • Priapism (a prolonged and painful erection lasting more than 4 hours)

  • Severe allergic reactions (e.g., rash, itching, swelling, severe dizziness, difficulty breathing)

If any of these serious side effects occur, immediate medical attention is required.

Contraindications and Precautions

Generic Tadalis-SX is contraindicated in certain populations and situations, including:

  • Patients who are taking nitrates or nitric oxide donors, as the combination can cause a severe drop in blood pressure.

  • Individuals with a known hypersensitivity to tadalafil or any of the excipients in the formulation.

  • Patients with severe hepatic or renal impairment, as the drug's clearance may be reduced, leading to an increased risk of adverse effects.

Precautions should be taken when prescribing Generic Tadalis-SX to patients with:

  • Cardiovascular diseases, particularly those with a history of myocardial infarction, stroke, or life-threatening arrhythmias within the last 6 months.

  • Anatomical deformation of the penis (e.g., Peyronie's disease) or conditions that may predispose to priapism (e.g., sickle cell anemia, multiple myeloma, leukemia).

  • Retinal disorders, as the use of PDE5 inhibitors has been associated with visual disturbances.

Drug Interactions

Generic Tadalis-SX can interact with several other medications, potentially altering its efficacy or increasing the risk of adverse effects. Notable drug interactions include:

  • Nitrates: Concurrent use with nitrates or nitric oxide donors can lead to a dangerous drop in blood pressure.

  • Alpha-blockers: The combination of Generic Tadalis-SX with alpha-blockers (used to treat hypertension or benign prostatic hyperplasia) can cause symptomatic hypotension.

  • CYP3A4 Inhibitors: Drugs that inhibit the CYP3A4 enzyme (e.g., ketoconazole, ritonavir) can increase tadalafil levels, necessitating dose adjustments.

  • CYP3A4 Inducers: Conversely, drugs that induce CYP3A4 (e.g., rifampin, phenytoin) can decrease tadalafil levels, potentially reducing its efficacy.

Patients should inform their healthcare provider of all medications they are taking, including prescription, over-the-counter, and herbal products, to avoid potential interactions.

Special Populations

  1. Elderly Patients:
    Elderly patients may be more sensitive to the effects of Generic Tadalis-SX, particularly if they have age-related renal impairment. Dose adjustments may be necessary in this population.

  2. Patients with Renal Impairment:
    In patients with mild to moderate renal impairment, the dose of Generic Tadalis-SX should be adjusted based on the severity of the impairment. It is not recommended for use in patients with severe renal impairment.

  3. Patients with Hepatic Impairment:
    Similar to renal impairment, dose adjustments are recommended for patients with mild to moderate hepatic impairment. The use of Generic Tadalis-SX is not advised in patients with severe hepatic impairment.

  4. Pediatric Patients:
    Generic Tadalis-SX is not indicated for use in pediatric populations, as its safety and efficacy have not been established in children.

Conclusion

Generic Tadalis-SX is a highly effective and well-tolerated medication for the treatment of erectile dysfunction and pulmonary arterial hypertension. Its long half-life, allowing for a prolonged duration of action, sets it apart from other PDE5 inhibitors and provides greater flexibility in dosing. While it is generally safe for most patients, it is essential to consider potential contraindications, precautions, and drug interactions to ensure its safe and effective use.

As with any medication, patients should consult their healthcare provider before starting Generic Tadalis-SX to determine the appropriate dosage and to discuss any potential risks or concerns. By doing so, individuals can maximize the benefits of this medication while minimizing the risk of adverse effects, ultimately improving their quality of life and overall well-being.

Testimonials

high quality medications

Free discreet shipping

Secure online transactions

Money-back guarantee

Fast worldwide delivery

By staying on our site you automatically agree with the storage and processing of your personal data, in accordance with our Privacy Policy.